<DOC>
	<DOC>NCT02710786</DOC>
	<brief_summary>To evaluate effect on comorbid disease and weight loss five years after Roux-en-Y gastric bypass (RYGB) surgery for morbid obesity.</brief_summary>
	<brief_title>Comorbidity Five Years After Gastric Bypass</brief_title>
	<detailed_description>Morbid obese patient frequently have comorbid diseases, e.g. diabetes, hypertension, hyperlipidemia, and sleep apnea. We will study the remission rate and weight loss five years after Roux-en-Y gastric bypass (RYGB) surgery in a nationwide large group of patients.</detailed_description>
	<mesh_term>Obesity, Morbid</mesh_term>
	<criteria>Registered individuals in Scandinavian Obesity Surgery Registry (SOReg) having had gastric bypass All other operations</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2016</verification_date>
</DOC>